Pippa White, senior global account director for Life Sciences at SAS, explores the reservations many in the industry have and highlights why now is the time to embrace analytics in the cloud.
Key insights:
- Athough almost every sector has embraced cloud-based solutions, which have driven significant progress, the life sciences industry still has its reservations.
- There's value in being able to spin up specific, highly customised environments for each project’s needs - one much easier to achieve in a cloud environment than on-premises.
- An analytics partner can provide a data science platform that encompasses classical statistics and AI, and governs the data science lifecycle from end to end.
Almost every sector has embraced cloud-based solutions which have driven significant progress, however, the life sciences industry has had its reservations. Regulatory scrutiny and reputational risk mean that information security is paramount where patient medical records are concerned, and the results of clinical trials are commercially sensitive too. As cloud-based systems continue to develop in functionality and safety, becoming a cornerstone of the cutting edge in most sectors, cloud analytics is becoming vital for modern demands.